Cargando…
Delivery strategies for CRISPR/Cas genome editing tool for retinal dystrophies: challenges and opportunities
CRISPR/Cas, an adaptive immune system in bacteria, has been adopted as an efficient and precise tool for site-specific gene editing with potential therapeutic opportunities. It has been explored for a variety of applications, including gene modulation, epigenome editing, diagnosis, mRNA editing, etc...
Autores principales: | Lohia, Aayushi, Sahel, Deepak Kumar, Salman, Mohd, Singh, Vivek, Mariappan, Indumathi, Mittal, Anupama, Chitkara, Deepak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shenyang Pharmaceutical University
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614410/ https://www.ncbi.nlm.nih.gov/pubmed/36320315 http://dx.doi.org/10.1016/j.ajps.2022.02.001 |
Ejemplares similares
-
Opportunities for CRISPR/Cas9 Gene Editing in Retinal Regeneration Research
por: Campbell, Leah J., et al.
Publicado: (2017) -
CRISPR/Cas Applications in Myotonic Dystrophy: Expanding Opportunities
por: Raaijmakers, Renée H.L., et al.
Publicado: (2019) -
New Editing Tools for Gene Therapy in Inherited Retinal Dystrophies
por: Pulman, Juliette, et al.
Publicado: (2022) -
CRISPR/Cas9 Genome Editing for Tissue‐Specific In Vivo Targeting: Nanomaterials and Translational Perspective
por: Sahel, Deepak Kumar, et al.
Publicado: (2023) -
CRISPR/Cas9 Genome Editing for Tissue‐Specific In Vivo Targeting: Nanomaterials and Translational Perspective
por: Sahel, Deepak Kumar, et al.
Publicado: (2023)